ESC Premium Access

The right glucose-lowering drugs for the right patient

Event: ESC CONGRESS 2019
Topic: Pharmacotherapy
Session type: Advances in Science
Date: 31 August 2019
Time: 13:45 - 14:55

Session

4 presentations in this session

State of the Art in antidiabetic treatment to prevent CVD

Speaker: Professor A. Norhammar (Stockholm, SE)
Thumbnail

Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study

Speaker: Mrs M. Fangel (Aalborg, DK)
Thumbnail

Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Speaker: Mrs M. Malik (Copenhagen, DK)
Thumbnail

Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus

Speaker: Doctor D. Berg (Boston, US)
Thumbnail

4 speakers from this session

Professor Anna Norhammar

Karolinska Institutet, Stockholm (Sweden)
4 presentations
0 follower

Mrs Mia Vicki Fangel

Aalborg University, Aalborg (Denmark)
0 follower

Mrs Mariam Elmegaard Malik

Gentofte University Hospital, Copenhagen (Denmark)
0 follower

Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk